Alembic Pharmaceuticals announced that it has received tentative approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA for Dronedarone Tablets USP 400 mg The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product RLD Multaq Tablets 400 mg of Sanofi-Aventis US LLC SanofiAventis Dronedarone is indicated to reduce the risk of hospitalization for atria fibrillation in […]
Advik Laboratories has adjourned the meeting of the Board of Directors which was scheduled to be held on 8 January 2022 The meeting will now be held on 10 January 2022
Rallis India will hold a meeting of the Board of Directors of the Company on 19 January 2022
Lexus Granito India will hold a meeting of the Board of Directors of the Company on 20 January 2022
RBL Bank and Google today announced a strategic collaboration to fuel the Banks customer experience strategy and expand its value proposition to serve its rapidly growing customer base through its digital platform Abacus 20 This collaboration will enable better customer data management and analytics enabling effective cross-selling within the Banks large customer base and subsequently reducing the cost of customer acquisition significantly Through Abacus 20 […]
Moschip Techs will hold a meeting of the Board of Directors of the Company on 17 January 2022
Tata Steel has increased its stake holding from 26Percentage to 51Percentage in joint venture company Medica TS Hospital on conversion of a 5102 Optionally Convertible Debentures OCD of Rs 1000 each fully paid-up held in MTSHPL into 510200 equity shares of face value Rs 10 each fully paid-up ranking pari passu with the existing equity shares of MTSHPL; and b 492298 OCDs of Rs 1000 […]
Rajratan Global Wire will hold a meeting of the Board of Directors of the Company on 18 January 2022
Marksans Pharma has received final approval from US Food Drugs Administration for its Abbreviated New Drug Application ANDA for over the counter OTC Cetirizine Hydrochloride Tablets 5 mg and 10mg It is indicated for the treatment of the perennial allergic rhinitis including sneezing rhinorrhea postnasal discharge watery eyes running nose The product will be marketed under store brand labels and is comparable to the brand […]
CCL Products India will hold a meeting of the Board of Directors of the Company on 19 January 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
